Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride

EU orphan designation number: EU/3/10/824   
Active ingredient: N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride
Indication: Treatment of acute myeloid leukaemia
Sponsor: Merck KGaA
Frankfurter Straße 250, D-64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Centralised Orphan - Designation EMA/OD/094/10 (2010)9537 of 17/12/2010